Keep dementia drugs on the PBS
This petition had 146 supporters
The availability of these drugs donepezil; rivastigmine; galantamine; and memantine are vital to people suffering from dementia and Alzheimer's disease. They are specifically designed for dementia to slow down progression of the disease, as well as ease symptoms. If these drugs are removed from the Pharmaceutical Benefits Scheme (PBS) it will make it very expensive (up to $150 a month) for people to access these medications. We need to be a voice for those unable to speak and keep these medications on the PBS.
Today: Kerri is counting on you
Kerri Cross needs your help with “The Pharmaceutical Benefits Advisory Committee: Keep dementia drugs on the PBS”. Join Kerri and 145 supporters today.